pegintron

Frequently asked questions

What does Pegintron treat?

Pegintron (Peginterferon Alfa-2b) may be used to treat brain neoplasms, renal cell carcinoma, cryoglobulinemia, hepatitis d, hemangioma, hepatocellular carcinoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

Is there a coupon or discount for Pegintron?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Pegintron. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Pegintron?

Pegintron is marketed by Schering. You can see Schering's full profile, rating, and other products on pharmaranks.

Is Pegintron a brand-name or generic drug?

Pegintron is a brand-name product with the active ingredient Peginterferon Alfa-2b.

Is Pegintron available over the counter?

No. Pegintron is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Pegintron come in?

Pegintron is currently marketed as injectable, per the FDA's National Drug Code Directory.

Is Pegintron FDA-registered?

Pegintron is on record with the U.S. FDA under application number BLA103949. You can verify this on its official FDA label.